QDEL [NASD]
Quidel Corporation
Index- P/E4.19 EPS (ttm)23.45 Insider Own1.60% Shs Outstand41.88M Perf Week6.31%
Market Cap3.78B Forward P/E20.08 EPS next Y4.90 Insider Trans-0.25% Shs Float36.76M Perf Month-15.25%
Income1.01B PEG0.58 EPS next Q3.18 Inst Own89.70% Short Float11.28% Perf Quarter11.18%
Sales2.33B P/S1.63 EPS this Y-11.60% Inst Trans-0.33% Short Ratio7.81 Perf Half Y-34.02%
Book/sh57.67 P/B1.71 EPS next Y-70.03% ROA42.60% Target Price160.00 Perf Year-18.44%
Cash/sh34.31 P/C2.87 EPS next 5Y7.20% ROE54.50% 52W Range88.05 - 180.06 Perf YTD-27.16%
Dividend- P/FCF7.81 EPS past 5Y110.10% ROI36.80% 52W High-45.39% Beta0.07
Dividend %- Quick Ratio3.90 Sales past 5Y54.70% Gross Margin73.50% 52W Low11.68% ATR4.69
Employees1600 Current Ratio4.30 Sales Q/Q167.10% Oper. Margin56.00% RSI (14)45.82 Volatility4.60% 4.89%
OptionableYes Debt/Eq0.00 EPS Q/Q176.40% Profit Margin43.30% Rel Volume1.33 Prev Close100.04
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout0.00% Avg Volume531.13K Price98.33
Recom2.00 SMA20-1.63% SMA50-7.65% SMA200-19.92% Volume703,803 Change-1.71%
Feb-22-22Upgrade Raymond James Outperform → Strong Buy $155 → $130
Jan-22-21Upgrade Raymond James Mkt Perform → Outperform $250
May-12-20Downgrade JP Morgan Neutral → Underweight $120 → $158
Mar-26-20Downgrade Barclays Overweight → Equal Weight $90
Oct-23-18Resumed Raymond James Strong Buy $80
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
May-19-22 06:28AM  
May-16-22 04:45PM  
04:45PM  
May-05-22 11:21AM  
09:52AM  
May-04-22 05:55PM  
04:10PM  
01:49PM  
Apr-30-22 10:43AM  
Apr-26-22 11:48AM  
Apr-25-22 05:45PM  
Apr-13-22 05:45PM  
Apr-12-22 06:00PM  
05:50PM  
10:10AM  
Apr-08-22 05:50AM  
Apr-07-22 04:10PM  
Apr-06-22 05:45PM  
08:30AM  
Mar-31-22 05:45PM  
Mar-25-22 05:45PM  
Mar-23-22 05:50PM  
Mar-22-22 11:36AM  
Mar-21-22 01:04PM  
Mar-17-22 10:00AM  
Mar-15-22 10:00AM  
08:30AM  
Mar-11-22 05:45PM  
10:32AM  
10:00AM  
Mar-10-22 10:51AM  
07:56AM  
Mar-07-22 09:40AM  
Mar-05-22 12:03AM  
Mar-04-22 10:52AM  
Mar-03-22 09:17AM  
Mar-02-22 12:53PM  
08:51AM  
Mar-01-22 02:43PM  
11:37AM  
Feb-28-22 06:30PM  
10:26AM  
10:16AM  
09:40AM  
Feb-25-22 08:30AM  
Feb-24-22 08:31AM  
08:27AM  
Feb-23-22 10:00AM  
Feb-22-22 03:54PM  
Feb-18-22 11:38AM  
11:28AM  
06:48AM  
05:47AM  
Feb-17-22 06:15PM  
04:10PM  
Feb-14-22 10:42AM  
Feb-10-22 03:01PM  
08:45AM  
Feb-08-22 05:45PM  
11:35AM  
09:38AM  
Feb-07-22 12:28PM  
Feb-04-22 03:00AM  
Feb-02-22 09:38AM  
Feb-01-22 04:10PM  
01:38PM  
Jan-31-22 05:45PM  
08:52AM  
07:41AM  
Jan-26-22 10:00AM  
Jan-24-22 11:31AM  
Jan-12-22 03:08PM  
11:20AM  
Jan-11-22 05:50PM  
10:10AM  
Jan-07-22 02:52AM  
Jan-06-22 04:10PM  
11:46AM  
09:45AM  
Jan-05-22 05:45PM  
04:24PM  
09:00AM  
09:00AM  
Jan-04-22 05:00PM  
08:50AM  
Jan-03-22 08:30AM  
07:05AM  
Dec-30-21 11:07AM  
Dec-29-21 01:15PM  
10:45AM  
03:05AM  
02:05AM  
Dec-28-21 06:00PM  
Dec-27-21 09:40AM  
Dec-24-21 11:31AM  
08:07AM  
Dec-23-21 06:30PM  
05:03PM  
01:42PM  
12:38PM  
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; Savanna, an automated in vitro molecular diagnostic platform; and Virena, a wireless cellular data management and surveillance system. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WIDDER KENNETH JDirectorMay 15Option Exercise0.001,028017,060May 17 07:55 PM
POLAN MARY LAKE PH DDirectorMay 15Option Exercise0.00867019,029May 17 07:49 PM
BUECHLER KENNETH FDirectorMay 10Option Exercise15.737,800122,69468,664May 12 08:12 PM
POLAN MARY LAKE PH DDirectorMar 18Sale113.591,525173,22718,162Mar 22 07:57 PM
SLACIK CHARLES PDirectorJan 25Option Exercise19.5412,086236,12324,067Jan 27 07:27 PM
POLAN MARY LAKE PH DDirectorSep 03Sale141.716,167873,91319,687Sep 08 07:56 PM
Kroll WernerSVP, R&DJul 01Option Exercise0.00982011,229Jul 02 06:08 PM
Ferenczy William J.SVP, Cardio/Metabolic UnitJun 12Option Exercise0.002,00007,324Jun 16 08:23 PM
Kroll WernerSVP, R&DMay 27Option Exercise0.004,376012,495Jun 01 07:56 PM